Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector

Autor: B. H. Oakes, Thierry Calandra, Chelsey Bennett, Kathryn E. Foulds, Ralf Wagner, Matthieu Perreau, Mark Parrington, Annette Ives, J. McElrath, Konstantin V. Pugachev, Bertram L. Jacobs, Thierry Roger, Georgia D. Tomaras, Mariano Esteban, Guido Ferrari, Nicole L. Yates, David C. Montefiori, Harold Kleanthous, Mario Roederer, Bryan T. Mayer, Karen V. Kibler, Giuseppe Pantaleo, S. Ding, M. Vaine, Sanjay Phogat, Benedikt Asbach, Beatriz Perdiguero, Shing Fen Kao, Deborah T. Weiss, A. G. Spies, Gregory J. Mize, Jim Tartaglia, Raphael Gottardo, Maryann Giel-Moloney

Publikováno v: Scientific Reports, Vol 9, Iss 1, Pp 1-15 (2019)
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Scientific reports, vol. 9, no. 1, pp. 20005
Scientific Reports
Digital.CSIC. Repositorio Institucional del CSIC
instname

Multiple approaches utilizing viral and DNA vectors have shown promise in the development of an effective vaccine against HIV. In this study, an alternative replication-defective flavivirus vector, RepliVax (RV), was evaluated for the delivery of HIV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c440ba3a669e2a4c5a0e11f58f180f82
http://hdl.handle.net/10261/241086